CDER Priority Analysis IDIQ

Provide expert consultants to provide technical assistance in identifying, developing, enhancing, applying or evaluating a wide range of quantitative and qualitative methods drawn from decision science, risk analysis, social science, health outcomes research, health systems research, health economics and other analytic disciplines. These methods will be applied in a variety of projects to enable FDA to use more comprehensive and rigorous methods of analysis, measures of effectiveness, measures of quality, and measures of value and other impacts on consumers, on public health, healthcare, regulated industry and other stakeholders.

The mission of the FDA’s Center for Drug Evaluation and Research (CDER) is to assure that safe, effective, and high quality drugs are available to the American people. CDER promotes and protects the health of the public throughout drug development, during the drug review process, and in continued safety monitoring following drug approval. To accomplish its mission, CDER must contend with many important challenges.